» Articles » PMID: 15123721

Hydrogen Peroxide Activates the Gas6-Axl Pathway in Vascular Smooth Muscle Cells

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2004 May 5
PMID 15123721
Citations 42
Authors
Affiliations
Soon will be listed here.
Abstract

Axl, a receptor tyrosine kinase, is involved in cell survival, proliferation, and migration. We have shown that Axl expression increases in the neointima of balloon-injured rat carotids. Because oxidative stress is known to play a major role in remodeling of injured vessels, we hypothesized that H(2)O(2) might activate Axl by promoting autophosphorylation. H(2)O(2) rapidly stimulated Axl tyrosine phosphorylation in rat vascular smooth muscle cells within 1 min that was maximal at 5 min (6-fold). The response to H(2)O(2) was concentration-dependent with EC(50) of approximately 500 microm. Axl phosphorylation was partly dependent on production of its endogenous ligand, growth arrest gene 6 (Gas6), because Axl-Fc, a fragment of Axl extracellular domain that neutralizes Gas6, inhibited H(2)O(2)-induced Axl phosphorylation by 50%. Axl phosphorylation by H(2)O(2) was also attenuated by warfarin, which inhibits Gas6 activity by preventing post-translational modification. In intact vessels Axl was phosphorylated by H(2)O(2), and Axl phosphorylation was inhibited by warfarin treatment in balloon-injured carotids. Akt, a downstream target of Axl, was phosphorylated by H(2)O(2)in Axl(+/+) mouse aorta but significantly inhibited in Axl(-/-) aorta. Intimal proliferation was decreased significantly in a cuff injury model in Axl(-/-) mice compared with Axl(+/+) mice. In summary, Axl is an important signaling mediator for oxidative stress in cultured vascular smooth muscle cells and intact vessels and may represent an important therapeutic target for vascular remodeling and response to injury.

Citing Articles

AXL as immune regulator and therapeutic target in Acute Myeloid Leukemia: from current progress to novel strategies.

Vandewalle N, De Beule N, De Becker A, de Bruyne E, Menu E, Vanderkerken K Exp Hematol Oncol. 2024; 13(1):99.

PMID: 39367387 PMC: 11453060. DOI: 10.1186/s40164-024-00566-8.


Evaluation of the Role of AXL in Fusion-positive Pediatric Rhabdomyosarcoma Identifies the Small-molecule Inhibitor Bemcentinib (BGB324) as Potent Chemosensitizer.

Danielli S, Wurth J, Morice S, Kisele S, Surdez D, Delattre O Mol Cancer Ther. 2024; 23(6):864-876.

PMID: 38471796 PMC: 11148551. DOI: 10.1158/1535-7163.MCT-23-0285.


Prognostic Value of Soluble AXL in Serum from Heart Failure Patients with Preserved and Reduced Left Ventricular Ejection Fraction.

Cristobal H, Enjuanes C, Batlle M, Tajes M, Campos B, Francesch J J Pers Med. 2023; 13(3).

PMID: 36983628 PMC: 10056687. DOI: 10.3390/jpm13030446.


GAS6/Axl is associated with AMPK activation and attenuates HO-induced oxidative stress.

Liang Z, Yang Y, Wu X, Lu C, Zhao H, Chen K Apoptosis. 2022; 28(3-4):485-497.

PMID: 36580193 DOI: 10.1007/s10495-022-01801-5.


AXL Receptor Tyrosine Kinase as a Promising Therapeutic Target Directing Multiple Aspects of Cancer Progression and Metastasis.

Goyette M, Cote J Cancers (Basel). 2022; 14(3).

PMID: 35158733 PMC: 8833413. DOI: 10.3390/cancers14030466.